SCHEMBL1150740

SCHEMBL1150740

Oc1ccccc1-c1cnc2ccccc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 3/20 0.54
PDGFRA P16234 3/20 0.54
CYP2A6 P11509 1/20 0.51
BIRC5 O15392 1/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA9 Q16790 1/20 0.50
PIK3CD O00329 1/20 0.49
PIK3CA P42336 1/20 0.49
KDM4E B2RXH2 2/20 0.48
ALDH1A1 P00352 2/20 0.48
HPGD P15428 2/20 0.48
MAP4K4 O95819 1/20 0.48
CSNK1G2 P78368 1/20 0.48
CLK4 Q9HAZ1 1/20 0.48
MKNK2 Q9HBH9 1/20 0.48
MAP4K5 Q9Y4K4 1/20 0.48
NPC1 O15118 1/20 0.48
LMNA P02545 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2772360 0.80 PDGFRB (0.77) PDGFRBPDGFRACYP2A6BIRC5CA12
SCHEMBL32667946 0.80 PDGFRB (0.77) PDGFRBPDGFRACYP2A6BIRC5CA12
SCHEMBL27659350 0.79 NPC1 (0.65) PIK3CAKDM4EALDH1A1HPGDNPC1
SCHEMBL15968103 0.79 CYP1A2 (0.56) PDGFRBPDGFRACYP2A6BIRC5CA12
SCHEMBL2198777 0.79 PDGFRB (0.60) PDGFRBPDGFRACYP2A6BIRC5CA12
SCHEMBL29375329 0.79 CYP1A2 (0.56) PDGFRBPDGFRACYP2A6BIRC5CA12
SCHEMBL30547072 0.79 PDGFRB (0.60) PDGFRBPDGFRACYP2A6BIRC5CA12
SCHEMBL32691828 0.79 PDGFRB (0.60) PDGFRBPDGFRACYP2A6BIRC5CA12
SCHEMBL2624503 0.79 PDGFRB (0.54) PDGFRBPDGFRACYP2A6BIRC5CA12
SCHEMBL29064903 0.78 PDGFRB (0.50) PDGFRBPDGFRACYP2A6BIRC5CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106187881-B One kind has the compound, preparation method and application of 3- (2- hydroxy phenyl) quinoline structure unit 河南大学 2019-04-23 CN claimed
CN-107714304-A A kind of paper diaper with urine detection function and preparation method thereof 上海速创诊断产品有限公司 2018-02-23 CN claimed
CN-106645676-A Multi-term urine analysis test paper and preparation method thereof 重庆普西医疗设备有限公司 2017-05-10 CN claimed
CN-104697993-A Urine data acquiring device and application method thereof WU YOUCAI 2015-06-10 CN claimed
CN-104622648-A Digital infant training pant WU YOUCAI 2015-05-20 CN claimed
CN-104622646-A Digital infant urine isolation pad WU YOUCAI 2015-05-20 CN claimed
CN-104622647-A Digital infant diaper WU YOUCAI 2015-05-20 CN claimed
CN-209059682-U A kind of paper diaper with urine detection function 上海速创诊断产品有限公司 2019-07-05 CN disclosed
CN-106187881-B One kind has the compound, preparation method and application of 3- (2- hydroxy phenyl) quinoline structure unit 河南大学 2019-04-23 CN disclosed
CN-106187881-B One kind has the compound, preparation method and application of 3- (2- hydroxy phenyl) quinoline structure unit 河南大学 2019-04-23 CN disclosed
CN-107714304-A A kind of paper diaper with urine detection function and preparation method thereof 上海速创诊断产品有限公司 2018-02-23 CN disclosed
CN-105636953-B 1,4 dibasic pyridyl derivatives and its purposes for treating the illness related to SMN shortages 诺华股份有限公司 2018-01-02 CN disclosed
CN-106645676-A Multi-term urine analysis test paper and preparation method thereof 重庆普西医疗设备有限公司 2017-05-10 CN disclosed
CN-201327492-Y Multi-term urine analysis test paper YANTAI BIOWAY BIOTECH CO LTD (CN) 2009-10-14 CN disclosed
EP-1496896-A4 INHIBITORS OF AKT ACTIVITY MERCK & CO INC (US) 2007-10-31 EP disclosed
CN-1993326-A Heterocyclic acetophenone potentiators of metabotropic glutamate receptors MERCK & CO INC (US) 2007-07-04 CN disclosed
US-7223738-B2 Inhibitors of Akt activity MERCK & CO., INC. (US) 2007-05-29 US disclosed
US-20050222155-A1 Inhibitors of akt activity MERCK SHARP & DOHME CORP. 2005-10-06 US disclosed
EP-1496896-A1 INHIBITORS OF AKT ACTIVITY Merck & Co., Inc. (US) 2005-01-19 EP disclosed
WO-2003086394-A1 INHIBITORS OF AKT ACTIVITY MERCK & CO., INC. (US) 2003-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222155-A1 Inhibitors of akt activity AKT1, AKT2, AKT3 PDGFRB 1134/4885PDGFRA 1412/4885CYP2A6 4559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.